Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease | Semantic Scholar
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease | Journal of the American Heart Association
The Lancet - Kawasaki disease is a self-limited vasculitis that is the most common cause of acquired heart disease in children in developed countries. Although intravenous immunoglobulin (IVIG) is effective therapy, 10–20%
IJMS | Free Full-Text | Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease | MDedge Pediatrics
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Treatment Options for Refractory Kawasaki Disease
An Overview of Kawasaki Disease
Understanding Kawasaki Disease
New Tool Twice as Accurate at Predicting Antibody Resistance Among U.S. Children with Kawasaki Disease - Be part of the knowledge - ReachMD
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine
Kawasaki Disease: Complications and Treatment | American Heart Association
Frontiers | Kawasaki Disease
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
JCI - Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
RAISE Study: New evidence of Kawasaki disease's treatment
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
2021 ACR/VF Kawasaki Guidelines - Vasculitis Foundation
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
IVIG Treatment for Kawasaki Disease | AmeriPharma™ Specialty
Clinical Practice Guidelines : Kawasaki disease
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
Frontiers | A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
